561 Results
Document
Document
Document
May 2019
Document
May 2019
Document
May 2019
Document
May 2019
Document
May 2019
Document
May 2019
Guidelines and Advice
Status: In-Review
ID: GL 2-24
ID: GL 2-24
May 2019
Drug
Jan 2026
Document
